文献速递血液净化与透析

高通量透析与对流透析模式对β2微球蛋白清除率的荟萃分析

Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该荟萃分析纳入69项研究、1879例患者,比较高通量透析(HFD)与对流疗法(血液滤过和血液透析滤过)对β2微球蛋白(β2M)的清除效率。结果显示对流疗法β2M清除率(87.06 mL/min)高于常规高通量透析(48.75 mL/min),膜材料、血流量和置换液速率显著影响清除率。

要点

  • 对流疗法β2M清除率87.06 mL/min,高于高通量透析的48.75 mL/min。
  • 聚芳醚砜膜用于HFD、聚砜膜用于对流疗法时β2M清除率更高。
  • 透析液侧β2M清除率显著低于全血清除率,提示吸附贡献大。

核心结论

  • 膜成分与特性、透析模式(对流 vs 弥散)、血流量和HDF置换液速率对β2M有效清除有显著作用。

研究设计与样本

  • 随机效应荟萃分析和荟萃回归,检索ProQuest、SCOPUS、EMBASE和MEDLINE,纳入2001年1月1日至2017年6月12日的69项研究,共1879例患者、6771次测量。

主要发现

  • 常规高通量透析的平均β2M清除率为48.75 mL/min(95%CI 42.50-55.21)。
  • 对流疗法(血液滤过和HDF)的平均β2M清除率为87.06 mL/min(95%CI 75.08-99.03),研究间异质性显著(P(Q)≤0.001)。
  • 多变量荟萃回归显示,聚芳醚砜膜用于HFD、聚砜膜用于对流疗法时β2M清除率显著更高。
  • 透析液侧β2M清除率显著低于全血清除率(调整后差值-22.279,95%CI -9.8至-34.757,P<0.001),提示吸附对β2M清除贡献显著。
  • 较高的超滤系数(Kuf)、血流量和置换液速率与β2M清除率显著且临床有意义的升高相关,透析液流量无此关联。

临床怎么用

  • 选择对流疗法或高通量透析时,应考虑膜材料(如聚芳醚砜、聚砜)、血流量和置换液速率以优化β2M清除。

局限性

  • 研究间异质性显著(P(Q)≤0.001),可能影响结果合并的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent meta-analyses suggest that higher removal of beta-2 microglobulin (β2M) with either high-flux (HFD) dialysis or hemodiafiltration (HDF) may be associated with decreased total and cardiovascular mortality in dialysis patients. However, there are limited data about the performance of high flux dialyzers and/or convective therapies in removing β2M. METHODS: This is a random effects meta-analysis and meta-regression of data extracted from randomized controlled trials and observational studies in hemodialysis, hemofiltration and HDF regarding the efficiency of high flux dialyzers to remove β2M. Studies were searched using ProQuest in SCOPUS, EMBASE and MEDLINE. RESULTS: We included 69 studies from 1 January 2001 to 12 June 2017 on 1879 patients with 6771 available measurements. Average β2M clearance was 48.75 mL/min [95% confidence interval (CI) 42.50-55.21] for conventional HF dialysis, and 87.06 mL/min (95% CI 75.08-99.03) for convective therapies (hemofiltration and HDF) with substantial heterogeneity among studies [P (Q) ≤ 0.001]. In multivariable meta-regression analyses, we found significantly higher β2M clearance for polyarylethersulfone dialyzers when used for HFD and polysulfone membranes in convective therapies. However, the mass of β2M removed into the dialysate did not depend on membrane material. Adjusted dialysate-side (-22.279, 95% CI -9.8 to -34.757, P < 0.001) β2M clearances were significantly lower than whole blood clearances, suggesting that adsorption contributes substantially to β2M removal. Higher Kuf, blood flow and substitution fluid rates but not dialysate flow rates were associated with statistically significant and clinically meaningful elevation in β2M clearance from the body independent of the dialysis modality. CONCLUSIONS: Membrane composition and characteristics, modality (convective versus diffusive), blood flow rates and substitution fluid rates in HDF play a significant role in the efficient removal of β2M from the body in both diffusive and convective dialysis.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Roumelioti ME, Trietley G, Nolin TD, et al. Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies. Nephrol Dial Transplant. 2018. PMID: 29186592. doi:10.1093/ndt/gfx311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。